Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities
Clinical trial NCT04864444 · COMPLETED
Trial details
- NCT number
- NCT04864444
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-19
- Primary completion
- 2022-12-31
- Enrollment
- 10715
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.